US Market
US stocks sink at open as coronavirus fears prompt California emergency
The Dow Jones fell 418.94 points, or 1.55%, at the open to 26,671.92The S&P 500 opened lower by 54.42 points, or 1.74%, at 3,075.70
1 min read5 Mar 2020Emerging markets keep up the growth tempo for Dr Reddy’s Laboratories
The company is also building new service lines such as hospitals and other business verticals on a B2B model Gross margin softened during the quarter, reflecting continuous price erosion in its key US market
2 min read3 Feb 2019Oil prices dip as worries over economic slowdown return
A partial US government shutdown and tepid economic data in some countries also dragged on broad financial markets
2 min read11 Jan 2019Bad liquidity or bad markets? Traders weigh in on stock tumult
More than $5 trillion has been erased from US stock values in the last three months as the S&P 500 slid within points of a bear market
3 min read29 Dec 2018Gold firms as dollar eases, markets brace for Fed
Gold prices rose to a five-month peak of $1,250.55 last week, but gave up their gains as the dollar strengthened
2 min read18 Dec 2018Oil drops as oversupply, economic growth worries weigh
Both US crude and Brent crude benchmarks fell more than 25 percent through October and November as a supply glut inflated global inventories but have stabilised over the last three weeks
2 min read17 Dec 2018Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US
Hetero Labs is recalling 15,94,092 bottles of Valsartan Tablets USP in the strengths of 40 mg, 80 mg, 160 mg and 320 mg, manufactured by the firm for Camber Pharmaceuticals, USFDA said in a report
1 min read29 Aug 2018GM seeks tariff exemption to keep China-made SUV on US market
General Motors asked the Trump administration to exclude its China-built Buick Envision from import tariffs, saying they would harm the company's ability to compete in the US luxury SUV market
1 min read3 Aug 2018Dr Reddy's to appeal US Court's decision on sale of generic Suboxone film
Dr Reddy's said it will appeal the decision of the US District Court of New Jersey regarding further sales and commercialisation of its Buprenorphine and Naloxone sublingual film in America
1 min read14 Jul 2018Dr Reddy's Q4: It's a wait and watch, share price spike notwithstanding
The US market continues to hold the key to an upward shift in Dr Reddy's performance in FY19, which can lead to an upgrade in the pharma firm's valuations
2 min read23 May 2018